[Acquired hemophilia A associated with bullous pemphigoid and multiple myeloma: a case report].

Ann Biol Clin (Paris)

Service d'hématologie-immunologie-transfusion, Hôpitaux Universitaires Paris Ile-de-France Ouest, CHU Ambroise Paré, Boulogne-Billancourt, France.

Published: April 2019

Acquired hemophilia A (AHA) is a rare and potentially severe bleeding disorder caused by circulating autoantibodies directed against factor (F) VIII. Apart from idiopathic cases, AHA is associated with autoimmune diseases, cancers, use of medications, pregnancy and the post-partum period. We report the case of a 78-year-old a male patient presenting with symptoms of a hematoma after a fall three days previously. He is medically followed for multiple myeloma and bullous pemphigoid. Laboratory investigations revealed isolated and recent increased of activated partial thromboplastin time (80,6/32,1s) and a markedly low FVIII activity (< 1%). The high-titer of FVIII inhibitor (19 Bethesda units/mL) confirmed the diagnosis of AHA diagnosis. The symptoms were noticeably alleviated following bortezomib, cyclophosphamide and dexamethasone therapy. This report describes a rare case of AHA associated with bullous pemphigoid and multiple myeloma. These pathologies induce an immunity modification that can predispose or be associated with the development of anti-FVIII inhibitors. This case illustrates two possible physiopathological hypotheses for the development of AHA, which will be discussed in this case report.

Download full-text PDF

Source
http://dx.doi.org/10.1684/abc.2018.1405DOI Listing

Publication Analysis

Top Keywords

bullous pemphigoid
12
multiple myeloma
12
associated bullous
8
pemphigoid multiple
8
aha associated
8
case
5
aha
5
[acquired hemophilia
4
associated
4
hemophilia associated
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!